[ Diabetes Solutions ]

Publications

The development of accurate and easy-to-use continuous glucose monitoring (CGM) improved diabetes treatment by providing additional temporal information on glycemia and glucose trends to patient and physician. Insulin glulisine (3(B)Lys29(B) Glu-human insulin) is a new fast-acting analog that provides absorption and onset of action more rapidly with a shorter duration of action compared with regular human insulin, and thus better resembles physiologic mealtime insulin requirements. Glycemic variability tends to increase as insulin function and/ or levels decline, beginning with obesity and glucose intolerance (pre-diabetes), worsening with the onset of type 2 diabetes, and still greater in subjects with long-standing type 2 diabetes.15–18 Increasing GV in type 2 diabetes is a reflection of the progressive loss of residual beta cell function while in type 1 diabetes, insulin deficiency is the major abnormality from early onset, and exogenous replacement is required to control glucose levels thus GV is usually much greater from the onset. Thus, there are unique challenges in caring for children and adolescents with T1D that differentiate pediatric from adult care. A visiting Professor at St. Patients were randomized to use one needle for 1 week, followed by the alternative needle for another week. Internal validation demonstrated that each mean event rate simulated by EAGLE overlapped with the published mean event (within a range of +/-10%).The EAGLE model is an evidence-based, internally valid tool for the assessment of the long-term effects of diabetes treatment and related costs.


They just measure something different. Those two fundamental aspects may have different meanings for different groups. Pierce JS, Kozikowski C, Lee JM, Wysocki T, Type 1 diabetes in very young children: a model of parent and child influences on management and outcomes. Pediatr Diabetes. Treatment of Patients with Obese Type 2 Diabetes with Tantalus-DIAMOND® Gastric Electrical Stimulation: Normal Triglycerides Predict Durable Effects for at Least 3 Years. Through the use of clear objectives for success and failure defined in the study, Schwartz effectively achieved the stated objective of demonstrating the validity of the ClikSTAR in being used correctly among the sample groups. Hemoglobin A1c (HbA1c) changes over time among adolescent and young adult participants in the T1D Exchange clinic registry.

Pediatr Diabetes. 2015 Jul 8. No relationship was observed between the increased dose and total daily insulin dose (P = 0.1224). Klingensmith GJ, Connor CG, Ruedy KJ, Beck RW, Kollman C, Haro H, Wood JR, Lee JM, Willi SM, Cengiz E, Tamborlane WV; Pediatric Diabetes Consortium. Presentation of youth with type 2 diabetes in the Pediatric Diabetes Consortium. Pediatr Diabetes. 2015 May 8.

Gregg B, Connor CG, Cheng P, Ruedy KJ, Beck RW, Kollman C, Schatz D, Cengiz E, Tamborlane WV, Klingensmith GJ, Lee JM; Pediatric Diabetes Consortium. Under this circumstance, metformin dose was reduced by 50%. PMID: 25180280; PMCID: PMC4179092. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group.

Tags: , ,
[ Diabetes Type 1 ]

PUBLICATIONS

I am a Tier II Canada Research Chair in Chronic Disease Prevention and Management, and a Professor in the first Canadian Accredited School of Public Health at the University of Alberta, Canada. 24, 2014 (HealthDay News) — Adults with diabetes are vulnerable to flu and its complications, experts say. Strong evidence supports the importance of physical activity in the management of Type 2 Diabetes. While Canada’s health-care community struggles to address the physical needs of Aboriginal patients with diabetes, Oster believes part of the solution lies in reconnecting them to their cultural roots. My colleagues and I are particularly interested in the evaluation of policies and alternative care delivery strategies to improve the quality and efficiency of care in diabetes. As a result, glucose builds up in the bloodstream, potentially leading to serious health problems such as blindness, heart disease, kidney problems, amputation, nerve damage and erectile dysfunction. The catch, though, is that this “trigger” doesn’t work in obesity, a setting in which blood lipid levels are usually high.

If the donor requires additional information that you may not have, please ask them to either visit diabetes.ca or call 1-800-BANTING (226-8464). As a trainee in clinical research, Doreen became involved with both ACHORD and the Gender and Sex Determinants of Cardiovascular Disease (GENESIS) Interdisciplinary Capacity Enhancement Team. The Society of Obstetricians and Gynecologists of Canada provides a variety of public education pamphlets designed for patients, clinics and health-care facilities. Our laboratory:   The Zochodne lab was established initially at Queen’s University, Kingston Ontario Canada in 1988 then moved to the University of Calgary in 1992 where it has remained and grown since. Please bring a towel and a change of workout wear. L. (2016) Antiaging Glycopeptide Protects Human Islets Against Tacrolimus-Related Injury and Facilitates Engraftment in Mice.

Fitness improvements amongst children in one Alberta First Nation after eight years of participatory research and Community commitment. If you have been diagnosed with a kidney disease, a Registered Dietitian, along with other members of your health care team, can help you improve your condition and enhance health by ensuring you get the nutrients your body needs in the right proportions. Each phase contributes new knowledge about the investigational drug or intervention bringing it one step closer to being a prescribed medication for population use. T., Willier, F., & Toth, E. She has experience as a consultant and advisor to government and non-government health care organizations in the UK and internationally, including acting as an advisor to the English Department of Health on its PROMs program. (2012, February). Fitness improvements amongst children in one Alberta First Nation after eight years of participatory research and Community commitment.

Oral presentation CDPAC 4th pan-Canadian conference: Integrated chronic disease prevention: It works!, Ottawa. Ralph-Campbell, K., Oster, R. T., Connor, T., MDSi Field Team, Jacobs, A., Cheng, A., …Toth, E. Blood ketone meters and strips are also available for more accurate or frequent testing. (2010, October). “Good news” and “bad news”: Results of screening for diabetes complications in remote, rural Alberta. Get ready for Junior High School fun!

Ralph-Campbell, K., Oster, R. This fall, the Behaviour Therapy and Learning Centre Ltd. L., Willier, F., Campiou, P., & Scott, T. (2010, October). Diabetes and cardiovascular risk in Driftpile First Nation: Longitudinal results. Poster presentation CDA/CSEM professional conference and annual meetings, Edmonton. Ralph-Campbell, K., Oster, R.

T., Toth, E. L., Willier, F., Scott, T., Campiou, P., & Quinn, K. (2010, October). The “next generation” of diabetes: Children at risk in Driftpile First Nation, Alberta. Poster presentation CDA/CSEM professional conference and annual meetings, Edmonton. Toth, E. L., Ralph-Campbell, K., Oster, R.

T., Connor, T., Pick, M., MDSi Field Team. (2009, October). Screening Indigenous communities for diabetes and its complications: 5 year results from a mobile diabetes outreach service in Alberta, Canada. Poster presentation International Diabetes Federation world diabetes congress, Montreal. Toth, E. L., Oster, R., Ralph-Campbell, K., Connor, T., Pick, M., Deschambeau, L., …Thompson, P. (2008, November).

Increasing rates of diabetes and cardiovascular risk in Métis Settlements in Alberta. Poster presentation 2nd international diabetes in Indigenous Peoples forum, Vancouver. Johnson, J. A., Vermeulen, S., Hugel, G., Toth, E., Hemmelgarn, B., Ralph-Campbell, K., & King, M. Increasing incidence and prevalence of diabetes among Status Aboriginal men in rural and urban Alberta. (2008, October). Poster presentation CDA/CSEM professional conference and annual meetings, Toronto.

Toth, E. L., Hemmelgarn, B., Crowshoe, L., Vermeulen, S. U., Hugel, G., King, M., …Johnson, J. A. Gomez J, Parkman HP (2009). Alberta Diabetes Surveillance System (ADSS): Diabetes atlas: Diabetes in First Nations. Poster presentation CDA/CSEM professional conference and annual meetings, Vancouver.

Toth, E. L., Ralph-Campbell, K., Pick, M., Connor, T., Meneen, K., & Fraser, G. (2007, October). Diabetes care and patient understanding of type 2 diabetes in remote, rural Alberta. Poster presentation CDA/CSEM professional conference and annual meetings, Vancouver. Toth, E. L., Ralph-Campbell, K., Connor, T., Meikle, A., Pick, M., Daniels, M., …Pohar, S.

(2007, October). Undiagnosed diabetes, pre-diabetes and cardiovascular risk in Alberta Métis Settlements: Results of the Mobile Diabetes Screening Initiative (MDSi). Oral presentation CDA/CSEM professional conference and annual meetings, Vancouver. Toth, E. L., Ralph-Campbell, K., Connor, T., Pick, M., Meneen, K., & Fraser, G. (2007, October). Results of a survey to assess patient memory of diagnosis and compliance with referral for physician follow-up after diabetes screening: The Mobile Diabetes Screening Initiative (MDSi).

Poster presentation CDA/CSEM professional conference and annual meetings, Vancouver. Ralph-Campbell, K., Supernault, S., Kaler, S. N., King, M., & Toth, E. L. (2006, February). Screening for diabetes in Indigenous communities in Alberta, Canada: Reframing bioethical considerations within an Indigenous context. Oral presentation New Zealand bioethics conference: Making people better, Dunedin.

Toth, E. L., Connor, T., Pick, M., Ralph-Campbell, K., & Meikle, A. (2006, February). Promises and pitfalls of a diabetes database. Oral presentation National Aboriginal Diabetes Association 4th annual conference on diabetes and Aboriginal Peoples, Winnipeg. Toth, E. L., Laboucan, R., Willier, F., Pick, M., & Ralph-Campbell, K.

(2006, February). The diabetes epidemic in Indigenous peoples: Is it stoppable?. Oral presentation National Aboriginal Diabetes Association 4th annual conference on diabetes and Aboriginal Peoples, Winnipeg. Toth, E. L., McEwen, S., Ralph-Campbell, K., Thompson, F., Daniels, M., Thompson, P., …Community Health Council #5. (2005, October). Screening Métis clients in rural Alberta for undiagnosed diabetes and cardiovascular risk factors.

Bridging the distance; 6th conference of the Canadian Rural Health Research Society & 1st conference of the Canadian Society for Circumpolar Health, Quebec City. Toth, E. L., McEwen, S., Friesen, D., Burke, P., Ralph-Campbell, K., & Prokopczak, D. (2005, October). Rationale and design of the Mobile Diabetes Screening Initiative (MDSI) for Aboriginal off reserve and remote communities in Alberta. Poster presentation CDA/CSEM professional conference and annual meetings, Quebec City. Ruiz, R., Toth, E.

L., Ralph-Campbell, K., & McEwen, S. (2005, October). Results of portable A1c, microalbumin and lipid testing in Area 2, Municipality of Cienfuegos, Cuba. Poster presentation CDA/CSEM professional conference and annual meetings, Quebec City. Toth, E. L., McEwen, S., Ralph-Campbell, K., Connor, T., Community Health Council #5, & Tri-Settlement Health Council. Screening Métis clients in Alberta for undiagnosed diabetes and cardiovascular risk factors.

Poster presentation CDA/CSEM professional conference and annual meetings, Quebec City.

Tags: , ,